PubHive is a UK-based cloud SaaS company positioned as a scientific literature and information workflow management platform. It targets literature processes across the life sciences lifecycle, from discovery research through post-marketing stages. Its website explicitly presents the product as an enterprise literature workflow upgrade solution or a QUOSA Alternative, serving teams in pharmaceuticals, biotechnology, medical devices and diagnostics, medical affairs, drug safety, regulatory affairs, HEOR, libraries, and research information management.
The publicly listed PubHive Navigator modules include Pulse, Quest, and Fetch. Pulse focuses on Drug Safety & Pharmacovigilance, supporting literature monitoring, PV literature search and management, signal detection and management, aggregate reports, and authoring. Quest is designed for systematic literature reviews, meta-analysis, literature searching, screening/review, data extraction, writing, and editing. Fetch is used for enterprise-level literature workflows across regulatory, medical affairs, R&D, CER/PMCF, medical writing, library, and document delivery scenarios. The website also lists use cases such as local/global PV literature automation, competitive intelligence, patent research, audit and inspection readiness, and document delivery.
For pricing, the website provides Pricing and Contact Sales entry points, but does not disclose plans, prices, seat counts, or usage rules. No free plan or trial information was found. Deployment is relatively clear: the company describes its offering as cloud-based software-as-a-service, indicating it is primarily a cloud SaaS product. On security and compliance, the footer includes Trust & Assurance, Privacy Policy, and AI Terms, and the site uses reCAPTCHA, but the main pages do not provide details on certifications, data encryption, permission auditing, or similar controls. Third-party integrations and Application Add-Ins are mentioned, but without naming specific systems; API and developer support are also only hinted at through Custom Development.
Its strengths are its strong industry focus, with workflows designed around specialized processes such as PV, medical affairs, regulatory work, and systematic reviews. The module boundaries are clear, making it suitable for life sciences organizations that need to replace traditional literature management tools or build enterprise-grade literature workflows. The downside is that the public information is more marketing- and navigation-oriented: key enterprise procurement details such as pricing, access controls, integrations, APIs, and security certifications are insufficient and need to be confirmed with sales.
The website does not provide information on access from China, Chinese localization, RMB payments, or local deployment, so its accessibility status is unknown. Chinese teams considering procurement should prioritize verification of network availability, cross-border data handling, contract and payment arrangements, audit compliance, and local support. Alternative directions include QUOSA as well as other pharmacovigilance literature monitoring, systematic review management, and enterprise literature delivery platforms.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pubhive.com official site.
pubhive.com is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach pubhive.com directly.